1.45
1.45 (0%)
As of Apr 17, 2025
Allogene Therapeutics, Inc. [ALLO]
Source:
Company Overview
Allogene Therapeutics, Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | (650) 457-2700 |
| Industry | manufacturing |
| CEO | David Chang, M.D., Ph.D. |
| Website | allogene.com |